BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun YT, Zhang YX, Tang H, Mao Q, Wang XZ, Zhang LY, Chen H, Zhong YN, Lin SM, Zhang DZ. Clinical characteristics and current management of hepatitis B and C in China. World J Gastroenterol 2014; 20(37): 13582-13590 [PMID: 25309089 DOI: 10.3748/wjg.v20.i37.13582]
URL: https://www.wjgnet.com/1007-9327/full/v20/i37/13582.htm
Number Citing Articles
1
Feng Zhou, Weidong Jia, Shuo Yang, Ge Chen, Guanhai Li, Yueping Li, Yingfang Liang, Yi Yang, Yanhui Gao, Yue Chen. Antiviral drug Utilization and Annual Expenditures for Patients with Chronic HBV Infection in Guangzhou, China, in 2008–2015Antiviral Therapy 2019; 24(6): 405 doi: 10.3851/IMP3326
2
Xiao-Wei Xu, Xiao-Xin Wu, Ke-Da Chen, Da-Zhi Chen, Hui-Lin Ou, Jun-Wei Su, Hai-Ying Yu, Hang-Ping Yao, Lan-Juan Li. Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, ChinaMedicine 2018; 97(38): e12403 doi: 10.1097/MD.0000000000012403
3
Mingjuan Tan, Ajeet S Bhadoria, Fuqiang Cui, Alex Tan, Judith Van Holten, Philippa Easterbrook, Nathan Ford, Qin Han, Ying Lu, Marc Bulterys, Yvan Hutin. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology 2021; 6(2): 106 doi: 10.1016/S2468-1253(20)30307-1
4
Vinh D Vu, Ailinh Do, Nghia H Nguyen, Lily H Kim, Huy N Trinh, Huy A Nguyen, Khanh K Nguyen, My Nguyen, Andrew Huynh, Mindie H Nguyen. Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to careBMJ Open Gastroenterology 2015; 2(1): e000060 doi: 10.1136/bmjgast-2015-000060
5
Nura Bello, Shuaibu A. Hudu, Ahmed S. Alshrari, Mustapha U. Imam, Abdulgafar O. Jimoh. Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping ReviewPathogens 2024; 13(7): 554 doi: 10.3390/pathogens13070554
6
Iris W. Liou, Mindie H. Nguyen. The Cascade of Care in Chronic Hepatitis BCurrent Hepatology Reports 2016; 15(4): 209 doi: 10.1007/s11901-016-0316-8
7
Hao Feng, Jie Yin, Ya-Ping Han, Xiao-Ying Zhou, Su Chen, Li Yang, Jin-Rui Yan, Guo-Xin Zhang. Sustained Changes of Treg and Th17 Cells During Interferon-α Therapy in Patients with Chronic Hepatitis BViral Immunology 2015; 28(8): 412 doi: 10.1089/vim.2015.0024
8
Matthew S. Chang, Mindie H. Nguyen. Epidemiology of hepatitis B and the role of vaccinationBest Practice & Research Clinical Gastroenterology 2017; 31(3): 239 doi: 10.1016/j.bpg.2017.05.008
9
Yu Zhijian, Li Hui, Yao Weiming, Lin Zhanzhou, Chen Zhong, Zheng Jinxin, Wang Hongyan, Deng Xiangbin, Yang Weizhi, Li Duoyun, Liu Xiaojun, Deng Qiwen. Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis BGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/906026
10
Ke-Qin Hu, Wei Cui, Susan D Rouster, Kenneth E Sherman. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individualsWorld Journal of Hepatology 2019; 11(5): 442-449 doi: 10.4254/wjh.v11.i5.442
11
Jian Tao, Weimin Zhang, Huakui Yue, Guohun Zhu, Wenyuan Wu, Wenbo Gong, Honghui Fang, Guirong He, Xiaoyun Hu, Hongyue Zhao, Aiqin Liu. Prevalence of Hepatitis B Virus Infection in Shenzhen, China, 2015–2018Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50173-5
12
Tingting Li, Shu Su, Yong Zhao, Runze Deng, Mingyue Fan, Ruoxi Wang, Manoj Sharma, Huan Zeng. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative ResearchInternational Journal of Environmental Research and Public Health 2019; 16(2): 231 doi: 10.3390/ijerph16020231
13
Mingyang Li, Hui Zhuang, Lai Wei. How would China achieve WHO’s target of eliminating HCV by 2030?Expert Review of Anti-infective Therapy 2019; 17(10): 763 doi: 10.1080/14787210.2019.1675509
14
Jinyuan Wei, Yongyu Mei, Jianping Li, Jing Yuan, Xiaohua Yang, Zhen Xu, Guoli Lin, Juan Zhang, Zhixin Zhao, Xiaohong Zhang. Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infectionLiver Research 2020; 4(2): 101 doi: 10.1016/j.livres.2020.05.002
15
Qin Ning, Ting Wu, Hai-Bin Su, Ke Ma, Jun-Ying Qi, Ming Ni, Di Wu. Acute Exacerbation of Chronic Hepatitis B2019; : 371 doi: 10.1007/978-94-024-1603-9_5
16
Qing Xie, Jian-Wei Xuan, Hong Tang, Xiao-Guang Ye, Peng Xu, I-Heng Lee, Shan-Lian Hu. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for ChinaWorld Journal of Hepatology 2019; 11(5): 421-441 doi: 10.4254/wjh.v11.i5.421